Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Common genetic variation of beta1- and beta2-adrenergic receptor and response to four classes of antihypertensive treatment.

Pharmacogenetics and genomics - 1 May 2010

Suonsyrjä Timo, Donner Kati, Hannila-Handelberg Tuula, Fodstad Heidi, Kontula Kimmo, Hiltunen Timo P

Abstract excerpt

Varying results have been reported on the association of beta-adrenergic receptor polymorphisms with blood pressure (BP) response to beta-blockers. We investigated the influence of ADRB1 Ser49Gly and Arg389Gly, and ADRB2 Gly16Arg and Glu27Gln polymorphisms on ambulatory BP response to bisoprolol and three other antihypertensive drug monotherapies in a placebo-controlled, double-blind, cross-over study with 233...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antihypertensive Agents
Share to Cross-Over Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Double-Blind Method

Share to Hypertension

Share to Pharmacogenetics

Share to Placebos

Share to Receptors, Adrenergic, beta-1

Share to Receptors, Adrenergic, beta-2

Source

Identifiers

PMID: 20300048
DOI: 10.1097/FPC.0b013e328338e1b8

Genes

ADRB1
ADRB2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Common genetic variation of beta1- and beta2-adrenergic receptor and response to four classes of antihypertensive treatment.PMID 20300048Read ↗

Association of common polymorphisms in β1-adrenergic receptor with antihypertensive response to carvedilol.Semantic proximity Read ↗

Pharmacogenetic polymorphisms affecting bisoprolol response.Semantic proximity Read ↗

Haplotypes of the adrenergic system predict the blood pressure response to beta-blockers in women with essential hypertension.Semantic proximity Read ↗

A46G and C79G polymorphisms in the β2-adrenergic receptor gene (ADRB2) and essential hypertension risk: a meta-analysis.Semantic proximity Read ↗

The pharmacogenetics of β-adrenergic receptor antagonists in the treatment of hypertension and heart failure.Semantic proximity Read ↗

β-Adrenergic Receptor Gene Polymorphisms and β-Blocker Treatment Outcomes in HypertensionSemantic proximity Read ↗

Beta-adrenoceptor polymorphisms.Semantic proximity Read ↗

Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta-Blocker Therapy.Semantic proximity Read ↗

Genetic polymorphisms influencing antihypertensive drug responsesSemantic proximity Read ↗

beta(2)-Adrenergic receptor polymorphisms and determinants of cardiovascular risk: the Cardiovascular Health Study.Semantic proximity Read ↗

Human beta2-adrenergic receptor polymorphisms: no association with essential hypertension in black or white Americans.Semantic proximity Read ↗

Pharmacogenetic factors affecting β-blocker metabolism and response.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.